Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. [electronic resource]
Producer: 20011214Description: 705-7 p. digitalISSN:- 0268-3369
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Antiviral Agents -- therapeutic use
- Bone Marrow Transplantation
- Combined Modality Therapy
- Cyclosporine -- therapeutic use
- Cystitis -- drug therapy
- Cytarabine -- administration & dosage
- Cytomegalovirus Infections -- drug therapy
- DNA, Neoplasm -- genetics
- Female
- Foscarnet -- therapeutic use
- Ganciclovir -- therapeutic use
- Graft vs Host Disease -- drug therapy
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Histocompatibility
- Humans
- Hydroxyurea -- administration & dosage
- Immunosuppressive Agents -- therapeutic use
- Interferon-alpha -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Methotrexate -- therapeutic use
- Mitoxantrone -- administration & dosage
- Neoplasms, Second Primary -- drug therapy
- Prednisolone -- therapeutic use
- Prostaglandins -- therapeutic use
- Remission Induction
- Topotecan -- administration & dosage
- Transplantation Conditioning
- Transplantation, Homologous
- Vidarabine -- analogs & derivatives
- Whole-Body Irradiation
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.